Near Complete Radiological Response to Palliative Chemotherapy Alone in Locally Advanced Squamous Cell Carcinoma of the Base of Tongue with Regional Metastasis: A Case Report
Main Article Content
Abstract
Background: Squamous cell carcinoma (SCC) of the base of tongue with regional nodal or contiguous parotid-bed involvement is typically managed with surgery and/or chemoradiotherapy; outcomes with chemotherapy alone in this setting are less well described, particularly in elderly, treatment-unfit patients.
Case Presentation: A 75-year-old man presented with a two-month history of progressive dysphagia and odynophagia. Magnetic resonance imaging (MRI) of the neck showed altered signal thickening of the right base of tongue, vallecula and floor of mouth, together with a separate 5.3 × 5.1 × 3.4 cm heterogeneous lesion in the deep lobe of the right parotid gland with locoregional soft-tissue extension. Biopsy of the tongue-base lesion confirmed moderately differentiated squamous cell carcinoma (Grade 2). Staging computed tomography (CT) of the thorax and abdomen showed no distant metastasis. Given the patient's age and comorbidities, he was treated with six cycles of palliative combination chemotherapy (paclitaxel and carboplatin). On completion of treatment, an interim contrast-enhanced CT of the neck showed no residual abnormality at the primary site or in the neck, with no lymphadenopathy. A subsequent post-treatment MRI of the neck, performed with the same modality used at baseline, confirmed this response: no discrete mass lesion was seen at the primary site or in the parotid bed, with only a small focal mucosal ulceration at the tongue base and a few small, non-specifically enlarged (subcentimetric) lymph nodes bilaterally.
Conclusion: This case documents a complete radiological response of locally advanced base-of-tongue SCC with parotid-bed/nodal involvement to six cycles of palliative paclitaxel–carboplatin chemotherapy alone, given without surgery or radiotherapy, in an elderly patient, confirmed on same-modality (MRI) post-treatment imaging. Clinical/endoscopic correlation of the residual mucosal ulceration is recommended as part of routine surveillance. The case adds to a small body of literature suggesting deep, durable responses are achievable with taxane–platinum chemotherapy alone in selected patients unfit for standard locoregional therapy.
Article Details
Issue
Section

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
References
1. Gebhardt BJ, Mendenhall CM, Morris CG, Kirwan JM, McAfee WJ, Mendenhall WM. Radiotherapy alone or combined with chemotherapy for base of tongue squamous cell carcinoma. Laryngoscope. 2017;127(7):1589–1594.
2. Pêtre A, Dalban C, Karabajakian A, Neidhardt EM, Roux PE, Poupart M, Deneuve S, Zrounba P, Fayette J. Carboplatin in combination with weekly paclitaxel as first-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma unfit to EXTREME schedule. Oncotarget. 2018;9(31):22038–22046.
3. Marín-Jiménez JA, Oliva M, Peinado Martín P, Cabezas-Camarero S, Plana Serrahima M, Vázquez Masedo G, et al. Paclitaxel plus cetuximab as induction chemotherapy for patients with locoregionally advanced head and neck
squamous cell carcinoma unfit for cisplatin-based chemotherapy. Front Oncol. 2022;12:953020.
4. Tachinami H, Tomihara K, Takatsuka D, Ikeda A, Yamada S, Noguchi M. Complete response to cetuximab plus paclitaxel therapy in nivolumab-refractory patients with distant metastasis of squamous cell carcinoma of the
tongue: a report of two cases. Cureus. 2023;15(11):e49198.
5. Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med. 2008;359(11):1116–1127.